Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Trafficking protein particle complex 2 pseudogene 9 (TRAPPC2P9) is a human pseudogene. Pseudogenes such as TRAPPC2P9 arise from gene duplication or retrotransposition events and typically do not encode functional proteins. TRAPPC2P9 is officially approved in the HUGO Gene Nomenclature Committee (HGNC) database as a pseudogene (HGNC ID:37733), and is synonymous with TRAPPC2P4B. No functional protein is known to be produced from this locus, and no clinical, pharmacological, or biochemical roles are currently attributed to TRAPPC2P9. It should not be conflated with TRAPPC9, which is a protein-coding gene involved in neuronal development, vesicle trafficking, and disease processes. If your intent was to find information on a therapeutic or diagnostic target, the correct gene is — Trafficking protein particle complex subunit 9 (TRAPPC9), not TRAPPC2P9.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Trafficking protein particle complex 2 pseudogene 9 (TRAPPC2P9).